Real-life efficacy and safety of biologic treatment in patients with moderate to severe psoriasis and previous diagnosis of a malignant tumor: Single-center descriptive study

被引：0
|
作者：
Duran Romero, Antonio Jose [1 ]
Fernandez Freire, Lourdes Rodriguez [1 ]
Sendin Martin, Mercedes [1 ]
Ortiz Alvarez, Juan [1 ]
Hernandez Rodriguez, Juan Carlos [1 ]
Conejo-Mir Sanchez, Julian [1 ]
机构：
[1] Univ Hosp Virgen Rocio, Dermatol Dept, Seville, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34115
引用
收藏
页码：AB198 / AB198
页数：1
相关论文
共 50 条
  • [41] SAFETY OF NON ANTI-TNF BIOLOGIC AGENTS IN RHEUMATIC PATIENTS WITH PAST HEPATITIS B VIRUS INFECTION. A SINGLE-CENTER REAL-LIFE STUDY
    Papalopoulos, I.
    Kougkas, N.
    Avgoustidis, N.
    Repa, A.
    Fanouriakis, A.
    Sidiropoulos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 511 - 511
  • [42] Long-term efficacy of secukinumab in Korean patients with moderate-to-severe plaque psoriasis in a real-world setting; A single-center, retrospective study
    Park, J.
    Lee, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S68 - S68
  • [43] Efficacy and safety of systemic isotretinoin treatment for moderate to severe acne (insights from the real-life clinical setting)
    Tolino, Ersilia
    Skroza, Nevena
    Proietti, Ilaria
    Mambrin, Alessandra
    Balduzzi, Veronica
    Marchesiello, Anna
    Maddalena, Patrizia
    Michelini, Simone
    Volpe, Salvatore
    Bernardini, Nicoletta
    Potenza, Concetta
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [44] SAFETY AND EFFICACY OF SOFOSBUVIR-BASED TREATMENT REGIMENS FOR CHRONIC HEPATITIS C VIRUS INFECTION: A "REAL-LIFE", SINGLE-CENTER EXPERIENCE IN 117 PATIENTS
    Wehmeyer, M. H.
    Eissing, C.
    Jordan, S.
    Lohse, A. W.
    zur Wiesch, J. Schulze
    Lueth, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S649 - S649
  • [45] EFFICACY AND SAFETY OF CANAKINUMAB IN ADULT-ONSET STILL'S DISEASE: A SINGLE-CENTER REAL-LIFE EXPERIENCE
    Tomelleri, A.
    Campochiaro, C.
    De Luca, G.
    Farina, N.
    Baldissera, E.
    Cavalli, G.
    Dagna, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 847 - 848
  • [46] Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study
    Ruggiero, Angelo
    Fabbrocicni, Gabriella
    Cacciapuoti, Sara
    Potestio, Luca
    Gallo, Lucia
    Megna, Matteo
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 529 - 536
  • [47] REALMS Study: Single-center retrospective observational single-center study of alemtuzumab (Lemtrada®) treatment in a Spanish cohort of multiple sclerosis patients under real-life conditions
    Eichau, S.
    Lopez-Ruiz, R.
    Dotor, J.
    Ruiz de Arcos, M.
    Ruiz-Pena, J. L.
    Navarro-Mascarell, G.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 716 - 716
  • [48] Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
    Turk, Murat
    Bahcecioglu, Sakine Nazik
    Tutar, Nuri
    Oymak, Fatma Sema
    Gulmez, Inci
    Yilmaz, Insu
    TURKISH THORACIC JOURNAL, 2018, 19 (04) : 187 - 192
  • [49] Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study
    Marsili, F.
    Travaglini, M.
    Stinco, G.
    Manzoni, R.
    Tiberio, R.
    Prignano, F.
    Mazzotta, A.
    Cannavo, S. P.
    Cuccia, A.
    Germino, M.
    Bongiorno, M. R.
    Persechino, S.
    Florio, T.
    Pettinato, M.
    Tabanelli, M.
    Sarkar, R.
    Aloisi, E.
    Bartezaghi, M.
    Orsenigo, R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 401 - 407
  • [50] Last stop Guselkumab? Treatment of plaque psoriasis in routine clinical care, real-life results from a single-center observational study
    Morrison, K.
    Baurecht, H.
    Mrowietz, U.
    Gerdes, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 95 - 95
12345